Evidence map›Paper›PMID 29788232›Full record

ArticleThe international journal of neuropsychopharmacology2018

Chronic Stress Exposure Reduces Parvalbumin Expression in the Rat Hippocampus through an Imbalance of Redox Mechanisms: Restorative Effect of the Antipsychotic Lurasidone.

Andrea C Rossetti, Maria Serena Paladini, Martina Colombo, Piotr Gruca, Magdalena Lason-Tyburkiewicz, Katarzyna Tota-Glowczyk, Mariusz Papp, Marco A Riva, Raffaella Molteni

Open access · goldAbstract read
In one paragraph

Article in The international journal of neuropsychopharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 50 citations in OpenAlex.

  1. Trial
  2. Parvalbumin interneurons under stress: converging mechanisms of vulnerability.The international journal of neuropsychopharmacology · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Mapping alterations in the local synchrony of the cerebral cortex in schizophrenia.European psychiatry : the journal of the Association of European Psychiatrists · 2023
    Article
  9. Altered regulation of oligodendrocytes associated with parvalbumin neurons in the ventral hippocampus underlies fear generalization in male mice.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  10. Venlafaxine's effect on resilience to stress is associated with a shift in the balance between glucose and fatty acid utilization.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Andrea C RossettiDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Maria Serena PaladiniDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Martina ColomboDepartment of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.
Piotr GrucaInstitute of Pharmacology, Polish Academy of Sciences, Krakow, Poland.
Magdalena Lason-TyburkiewiczInstitute of Pharmacology, Polish Academy of Sciences, Krakow, Poland.
Katarzyna Tota-GlowczykInstitute of Pharmacology, Polish Academy of Sciences, Krakow, Poland.
Mariusz PappInstitute of Pharmacology, Polish Academy of Sciences, Krakow, Poland.
Marco A RivaDepartment of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.
Raffaella MolteniDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
University of Milan · ITPolish Academy of Sciences · PLMaj Institute of Pharmacology · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Psychiatric disorders are associated with altered function of inhibitory neurotransmission within the limbic system, which may be due to the vulnerability of selective neuronal subtypes to challenging environmental conditions, such as stress. In this context, parvalbumin-positive GABAergic interneurons, which are critically involved in processing complex cognitive tasks, are particularly vulnerable to stress exposure, an effect that may be the consequence of dysregulated redox mechanisms. Methods: Adult Male Wistar rats were subjected to the chronic mild stress procedure for 7 weeks. After 2 weeks, both control and stress groups were further divided into matched subgroups to receive chronic administration of vehicle or lurasidone (3 mg/kg/d) for the subsequent 5 weeks. Using real-time RT-PCR and western blot, we investigated the expression of GABAergic interneuron markers and the levels of key mediators of the oxidative balance in the dorsal and ventral hippocampus. Results: Chronic mild stress induced a specific decrease of parvalbumin expression in the dorsal hippocampus, an effect normalized by lurasidone treatment. Interestingly, the regulation of parvalbumin levels was correlated to the modulation of the antioxidant master regulator NRF2 and its chaperon protein KEAP1, which were also modulated by pharmacological intervention. Conclusions: Our findings suggest that the susceptibility of parvalbumin neurons to stress may represent a key mechanism contributing to functional and structural impairments in specific brain regions relevant for psychiatric disorders. Moreover, we provide new insights on the mechanism of action of lurasidone, demonstrating that its chronic treatment normalizes chronic mild stress-induced parvalbumin alterations, possibly by potentiating antioxidant mechanisms, which may ameliorate specific functions that are deteriorated in psychiatric patients.

Indexed as

AnimalsAntipsychotic AgentsChronic DiseaseDisease Models, AnimalGABAergic NeuronsGene ExpressionHippocampusInterneuronsKelch-Like ECH-Associated Protein 1Lurasidone HydrochlorideMaleNADPH Oxidase 2NF-E2-Related Factor 2Oxidation-ReductionParvalbuminsRats, WistarAntipsychotic AgentsKEAP1 protein, ratKelch-Like ECH-Associated Protein 1Lurasidone HydrochlorideNADPH Oxidase 2Nfe2l2 protein, ratNF-E2-Related Factor 2ParvalbuminsRNA, Messenger

Identifiers

PMID29788232
PMCPMC6119300
OpenAlexW2804319053

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.